Featuring summaries of scientific presentations.

Novartis recognizes the public health dependence on better usage of vaccines and medicines in developing countries. Novartis is working closely with developing countries and international health agencies to find sustainable solutions for effective distribution of important medicines for diseases such as malaria, meningitis, tuberculosis and leprosy. In November 2009 Celtura was approved for use in both Germany and Switzerland, and Novartis is looking for approval in several other countries also.Even so, four international clinical trials have proven colloidal silver’s efficacy without destroying helpful bacterias. Some hospitals use silver coated catheters and colloidal silver bandages, among burn victims especially, to reduce potential infections.But hospitals are currently more interested in another steel to lessen infections from hospitals. That steel is certainly copper. This copper isn’t in colloidal suspensions.